ArticleMacromolecular rapid communications2026
Molecular Design of Biobased, Printable Monomers for Two-Photon Polymerization.
Article in Macromolecular rapid communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
This study reports the strategic molecular design of a range of novel multi-acrylate monomers derived from the terpenoids nopol and verbenol, and their successful use in two-photon polymerization (2PP). This design process allowed the identification of structures most appropriate for use in additive manufacturing (AM) resins. This was achieved by deriving new synthesis routes that enabled the fabrication of monomers with bespoke numbers and placements of vinyl groups, which were then shown to dictate the level of success achieved in resin-based AM processing. By identifying the correct molecular design, it was demonstrated via 2PP that structures with uniform composition, smooth surfaces, and finely resolved features could be printed, as confirmed by scanning electron microscopy (SEM). 2PP is a high-precision 3D-printing technique for fabricating complex micro- and nano-scale structures. Despite its potential in functional devices, advanced manufacturing, and biomedical applications, the range of biobased monomers suitable for 2PP remains limited, and they are typically derived from petrochemical sources. This study also demonstrated that terpene and terpenoid reagents, which are abundant and renewable natural compounds, offer a promising platform for developing biobased, multifunctional monomers for AM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.